NCT07815522
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
- Locations
-
- the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Clinical trial condition
Salivary Gland Carcinoma
Explore clinical trials studying Salivary Gland Carcinoma. Study availability and eligibility vary by location and protocol.
10 public trials
2 recruiting studies
Salivary Gland Carcinoma trial results
Recruiting
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
NCT06145308
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +7 more
- Locations
-
- Fei Ma Beijing, Beijing Municipality, China
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China
Active, not recruiting
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
NCT05075980
- Conditions
- Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary, +36 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
Active, not recruiting
Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma
NCT03942653
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
- Locations
-
- Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
- University of Illinois Cancer Center Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Univeristy of Maryland Baltimore, Maryland, United States
Active, not recruiting
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT07118176
- Conditions
- Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +127 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Active, not recruiting
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
NCT02628067
- Conditions
- Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
- Locations
-
Not specified
NCT03749460
- Conditions
- Head and Neck Neoplasms, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lung, +12 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03602079
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
- Locations
-
- Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
- Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Clinical Research Alliance, Inc. Lake Success, New York, United States
NCT03132038
- Conditions
- Disease Attributes, Head and Neck Neoplasms, Metastatic Cancer, +14 more
- Locations
-
- CHU Bordeaux Bordeaux, France
- Centre Georges François Leclerc Dijon, France
- Centre Léon Bérard Lyon, France
- ICM Val d'Aurelle Montpellier, France
Completed
Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma
NCT02393820
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
- Locations
-
- Institut de Cancérologie de l'Ouest Paul Papin Angers, France
- CHU Bordeaux Bordeaux, France
- Centre Jean Perrin Clermont-Ferrand, France
- Centre Georges François Leclerc Dijon, France